Skip to main content
. 2022 Jul 8;7(4):100529. doi: 10.1016/j.esmoop.2022.100529

Table 3.

Summary of immune-related adverse events (regardless of attribution to treatment) (N = 94)

Immune-related adverse events, n (%) Any grade Grade ≥3
Any 24 (25.5) 6 (6.4)
 Hypothyroidism 8 (8.5) 0
 Hyperthyroidism 4 (4.3) 0
 Pruritus 4 (4.3) 0
 Pneumonitis 3 (3.2) 1 (1.1)
 Rash maculopapular 2 (2.1) 1 (1.1)
 Acute kidney injury 1 (1.1) 1 (1.1)
 Adrenal insufficiency 1 (1.1) 1 (1.1)
 Colitis 1 (1.1) 0
 Dermatitis 1 (1.1) 0
 Interstitial lung disease 1 (1.1) 1 (1.1)
 Myositis 1 (1.1) 0
 Palmar-plantar erythrodysesthesia syndrome 1 (1.1) 0
 Rash 1 (1.1) 1 (1.1)
 Rash erythematous 1 (1.1) 0